Value Proposition:
• This technology has an application to address a major patient need.
• The ability to reliably diagnose malaria infections.
• The monoclonal antibodies specific to aldolase.
Technical Details:
Malaria is severe disease and caused by a parasite called Plasmodium. According to the World Health Organization, there were 247 million malaria cases and nearly a million deaths in 2006. Key intervention to control malaria is prompt and effective treatment with first step of good and reliable diagnostic testing. Hybridoma Clone 2B4. 5C9 or 2B4 6C1 producing the monoclonal antibodies that are specific to an abundant malaria protein called aldolase, which recognizes all species of Plasmodium.
Looking for Partners:
The antibody can be used for diagnostic testing or immunohistochemical detection of the malaria parasite.
